Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
المصدر:
Nasdaq GlobeNewswire
/
09 ديسمبر 2023 12:00:00 America/New_York
N/A
شارك على،